MedMen Enterprises Inc. (MMNFQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
MedMen Enterprises Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 25, 2023 | Jun '22 Jun 25, 2022 | Jun '21 Jun 26, 2021 | Jun '20 Jun 27, 2020 | Jun '19 Jun 29, 2019 | Jun '18 Jun 30, 2018 |
| 120.12 | 140.81 | 132.25 | 155.29 | 119.92 | 39.78 | |
Revenue Growth (YoY) | -17.45% | 6.48% | -14.84% | 29.49% | 201.43% | 1388.99% |
Cost of Revenue | 63.44 | 71.08 | 71.52 | 99.94 | 64.47 | 25.93 |
Gross Profit | 56.68 | 69.73 | 60.73 | 55.35 | 55.45 | 13.85 |
Selling, General & Admin | 74.89 | 111.93 | 110.18 | 203.41 | 266.89 | 104.5 |
Other Operating Expenses | -2.63 | -4.96 | -0.23 | 0.71 | 7.23 | - |
Operating Expenses | 89.21 | 131.03 | 136.26 | 241.78 | 296.18 | 109.76 |
Operating Income | -32.53 | -61.3 | -75.53 | -186.43 | -240.73 | -95.91 |
Interest Expense | -38.9 | -43.07 | -52.75 | -38.94 | -20.69 | -16.11 |
Interest & Investment Income | 0.09 | 0.09 | 0.65 | 0.77 | 0.7 | - |
Other Non Operating Income (Expenses) | 2.8 | 26.19 | 0.84 | 8.8 | 3.91 | 1.99 |
EBT Excluding Unusual Items | -68.53 | -78.1 | -126.79 | -215.81 | -256.81 | -110.03 |
Merger & Restructuring Charges | 0.08 | -2.32 | -5.04 | -6.27 | - | -0.7 |
Impairment of Goodwill | -23.09 | -23.09 | - | -33.47 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | 7.93 | 4.26 | - |
Gain (Loss) on Sale of Assets | -1.56 | -4.45 | 12.03 | 15.77 | -9.32 | - |
Asset Writedown | -86.48 | -78.71 | -2.36 | -213.24 | - | - |
Other Unusual Items | 0.56 | 11.22 | -0.33 | -52.43 | -1.16 | - |
Pretax Income | -176.91 | -175.45 | -122.5 | -497.51 | -263.03 | -110.73 |
Income Tax Expense | -20.07 | -9.9 | 1.83 | -40.93 | -6.37 | 3.09 |
Earnings From Continuing Operations | -156.84 | -165.55 | -124.33 | -456.58 | -256.66 | -113.81 |
Earnings From Discontinued Operations | 8.52 | -45.34 | -33.27 | -69.95 | -1.26 | - |
Net Income to Company | -148.33 | -210.89 | -157.6 | -526.53 | -257.92 | -113.81 |
Minority Interest in Earnings | 13.53 | 15.71 | 33.45 | 279.27 | 188.84 | 46.2 |
Net Income | -134.79 | -195.19 | -124.15 | -247.26 | -69.08 | -67.62 |
Preferred Dividends & Other Adjustments | - | - | 6.36 | - | - | - |
Net Income to Common | -134.79 | -195.19 | -130.51 | -247.26 | -69.08 | -67.62 |
Shares Outstanding (Basic) | 1,304 | 1,154 | 531 | 270 | 106 | 40 |
Shares Outstanding (Diluted) | 1,304 | 1,154 | 531 | 270 | 106 | 40 |
Shares Change (YoY) | 29.70% | 117.25% | 96.36% | 155.32% | 161.65% | - |
EPS (Basic) | -0.10 | -0.17 | -0.25 | -0.91 | -0.65 | -1.67 |
EPS (Diluted) | -0.10 | -0.17 | -0.25 | -0.91 | -0.65 | -1.67 |
Free Cash Flow | -31.17 | -71.57 | -62.11 | -167.15 | -359.9 | -128.47 |
Free Cash Flow Per Share | -0.02 | -0.06 | -0.12 | -0.62 | -3.40 | -3.17 |
Gross Margin | 47.19% | 49.52% | 45.92% | 35.64% | 46.24% | 34.81% |
Operating Margin | -27.08% | -43.54% | -57.12% | -120.06% | -200.74% | -241.08% |
Profit Margin | -112.21% | -138.62% | -98.69% | -159.23% | -57.60% | -169.96% |
Free Cash Flow Margin | -25.95% | -50.83% | -46.96% | -107.64% | -300.12% | -322.92% |
EBITDA | -14.41 | -35.65 | -47.06 | -145.92 | -217.05 | -89.88 |
EBITDA Margin | -11.99% | -25.32% | -35.58% | -93.97% | -180.99% | -225.92% |
D&A For EBITDA | 18.12 | 25.65 | 28.48 | 40.51 | 23.68 | 6.03 |
EBIT | -32.53 | -61.3 | -75.53 | -186.43 | -240.73 | -95.91 |
EBIT Margin | -27.08% | -43.54% | -57.12% | -120.06% | -200.74% | -241.08% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.